Ontology highlight
ABSTRACT: Objectives
This study assessed 5 frequently applied arterial 18fluorodeoxyglucose (18F-FDG) uptake metrics in healthy control subjects, those with risk factors and patients with cardiovascular disease (CVD), to derive uptake thresholds in each subject group. Additionally, we tested the reproducibility of these measures and produced recommended sample sizes for interventional drug studies.Background
18F-FDG positron emission tomography (PET) can identify plaque inflammation as a surrogate endpoint for vascular interventional drug trials. However, an overview of 18F-FDG uptake metrics, threshold values, and reproducibility in healthy compared with diseased subjects is not available.Methods
18F-FDG PET/CT of the ca
SUBMITTER: van der Valk FM
PROVIDER: S-EPMC5056585 | biostudies-literature | 2016 Oct
REPOSITORIES: biostudies-literature